Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2003
Acute effects of growth hormone on vascular function in human subjects
Raffaele Napoli, Vincenzo Guardasole, Valentina Angelini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 10, 2021
Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society
Raffaele Napoli, Angelo Avogaro, Gloria Formoso, et al.
Journal of the American College of Cardiology
|
January 5, 2002
Growth hormone corrects vascular dysfunction in patients with chronic heart failure
Raffaele Napoli, Vincenzo Guardasole, Margherita Matarazzo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
February 2, 2013
The GH/IGF-1 axis in chronic heart failure
Michele Arcopinto, Emanuele Bobbio, Eduardo Bossone, et al.
Minerva Endocrinologica
|
November 23, 2018
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes
Antonio Nicolucci, Giuseppe Prosperini, Raffaella Buzzetti, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2016
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme
Fabio Broglio, Edoardo Mannucci, Raffaele Napoli, et al.
Metabolism: Clinical and Experimental
|
July 29, 2004
Food and red wine do not exert acute effects on vascular reactivity
Raffaele Napoli, Vincenzo Guardasole, Valentina Angelini, et al.
Diabetes, Obesity & Metabolism
|
May 23, 2018
More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L
Juan Frias, Manuel Puig Domingo, Luigi Meneghini, et al.
Clinical Epigenetics
|
August 22, 2024
DNA methylation in cardiovascular disease and heart failure: novel prediction models?
Antonella Desiderio, Monica Pastorino, Michele Campitelli, et al.
Angiology
|
June 20, 2020
Peripheral Vascular Function in Dilated Cardiomyopathy of Different Etiology
Giorgio Bosso, Antonio Valvano, Valentina Apuzzi, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2003
Acute effects of growth hormone on vascular function in human subjects
Raffaele Napoli, Vincenzo Guardasole, Valentina Angelini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
October 10, 2021
Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society
Raffaele Napoli, Angelo Avogaro, Gloria Formoso, et al.
Journal of the American College of Cardiology
|
January 5, 2002
Growth hormone corrects vascular dysfunction in patients with chronic heart failure
Raffaele Napoli, Vincenzo Guardasole, Margherita Matarazzo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
February 2, 2013
The GH/IGF-1 axis in chronic heart failure
Michele Arcopinto, Emanuele Bobbio, Eduardo Bossone, et al.
Minerva Endocrinologica
|
November 23, 2018
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes
Antonio Nicolucci, Giuseppe Prosperini, Raffaella Buzzetti, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2016
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme
Fabio Broglio, Edoardo Mannucci, Raffaele Napoli, et al.
Metabolism: Clinical and Experimental
|
July 29, 2004
Food and red wine do not exert acute effects on vascular reactivity
Raffaele Napoli, Vincenzo Guardasole, Valentina Angelini, et al.
Diabetes, Obesity & Metabolism
|
May 23, 2018
More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L
Juan Frias, Manuel Puig Domingo, Luigi Meneghini, et al.
Clinical Epigenetics
|
August 22, 2024
DNA methylation in cardiovascular disease and heart failure: novel prediction models?
Antonella Desiderio, Monica Pastorino, Michele Campitelli, et al.
Angiology
|
June 20, 2020
Peripheral Vascular Function in Dilated Cardiomyopathy of Different Etiology
Giorgio Bosso, Antonio Valvano, Valentina Apuzzi, et al.
Page
of 6